Assyro AI

FDA Orange Book · active-ingredient family

Glutethimide

Glutethimide is approved as 1 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DORIDEN · NDA 009519

1

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, tablet

ProductApplicantApplicationTEApproved
DORIDEN×3SANOFI AVENTIS USNDA 009519Approved Prior to Jan 1, 1982

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
GLUTETHIMIDEHALSEYANDA 089458Oct 10, 1986
GLUTETHIMIDEHALSEYANDA 089459Oct 10, 1986
GLUTETHIMIDELANNETTANDA 083475Approved Prior to Jan 1, 1982
GLUTETHIMIDELANNETTANDA 085571Approved Prior to Jan 1, 1982
GLUTETHIMIDEUCB INCANDA 085171Approved Prior to Jan 1, 1982
GLUTETHIMIDEUPSHER SMITH LABSANDA 083234Approved Prior to Jan 1, 1982
GLUTETHIMIDEVITARINEANDA 087297Approved Prior to Jan 1, 1982
GLUTETHIMIDEWATSON LABSANDA 084362Approved Prior to Jan 1, 1982
GLUTETHIMIDEWATSON LABSANDA 085763Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Glutethimide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.